Shield Therapeutics plc is a specialty pharmaceutical company that develops and commercialises medicines for iron deficiency. Its main product is an oral iron therapy, marketed under different brand names in Europe and the United States, which is used to treat iron deficiency anaemia in adults. The company works with healthcare professionals and partners to make its treatment available to patients, and it is based in the United Kingdom.
Shield Therapeutics plc trades under the code STX on the London Stock Exchange in UK, with its price quoted in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3290 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
9/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-23.1%
From 52-week high-55.3%
MomentumWeak
21/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-4.4%
6-month return-38.4%
12-month, skipping last month-25.2%
Stability (higher is calmer)Weak
11/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)71.5%
Worst drawdown, 1 year (smaller is calmer)-69.7%
LiquidityStrong
75/100
Trades actively.
See the numbers →
Avg daily value traded12.07M GBX
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 3.700 – 12.500Daily closes, split-adjusted
Signals
50-day average5.232
200-day average7.090
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.308
Technical summary
Daily
Neutral
7 bullish · 4 neutral · 5 bearish
Weekly
Bearish
4 bullish · 1 neutral · 7 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
5.43
Bullish
EMA 10
5.47
Bearish
SMA 20
5.52
Bearish
EMA 20
5.42
Bullish
SMA 50
5.23
Bullish
EMA 50
5.35
Bullish
SMA 100
5.44
Bullish
EMA 100
5.68
Bearish
SMA 200
7.09
Bearish
EMA 200
6.24
Bearish
Oscillators (daily)
RSI (14)
52.39
Neutral
MACD (12, 26)
0.07
Bullish
Momentum (12)
2.83
Bullish
Stochastic %K (14)
58.82
Neutral
Williams %R (14)
-41.18
Neutral
CCI (20)
-28.28
Neutral
Pivot points (classic, last session)
S3
5.13
S2
5.22
S1
5.33
Pivot
5.42
R1
5.53
R2
5.62
R3
5.73
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in GBX. Educational only, not financial advice.
